Expertise in
13
conditions

Dr. Kenneth E. Sherman

Gastroenterology
Thoma & Sutton EyeCare Professionals LLC
222 Piedmont Ave, 
Cincinnati, OH 
Accepting New Patients
41 Years of Experience
Expertise in
13
conditions
Thoma & Sutton EyeCare Professionals LLC
222 Piedmont Ave, 
Cincinnati, OH 

Overview

Kenneth Sherman is a Gastroenterologist practicing medicine in Cincinnati, Ohio. He has been practicing medicine for over 41 years.

Dr. Sherman is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Hepatitis, Cirrhosis, Hepatitis C, Liver Transplant, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 168 peer reviewed articles and participating in 5 clinical trials. Dr. Sherman is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in OH

Hospital Affiliations

Massachusetts General Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO

Locations

Thoma & Sutton EyeCare Professionals LLC
222 Piedmont Ave, Cincinnati, OH 45219

Additional Areas of Focus

Dr. Sherman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Enrollment Status: Completed
Publish Date: December 06, 2021
Intervention Type: Drug
Study Phase: Phase 4
Phase I, Randomized, Open-Label, Active-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability & Immunogenicity of INO-1800 Alone or in Combination With INO-9112 Delivered IM Followed by EP in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
Phase I, Randomized, Open-Label, Active-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability & Immunogenicity of INO-1800 Alone or in Combination With INO-9112 Delivered IM Followed by EP in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
Enrollment Status: Completed
Publish Date: October 15, 2019
Intervention Type: Biological, Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

168 Total Publications

Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination.
Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 26, 2025
Similar Doctors
Expertise in
32
conditions
Dr. Andrew Ofosu
Gastroenterology
Expertise in
32
conditions
Dr. Andrew Ofosu
Gastroenterology
Referral may be required

Thoma & Sutton EyeCare Professionals LLC

222 Piedmont Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-475-7505
Languages Spoken:
English, Igbo
See accepted insurances
Accepting New Patients

Andrew Ofosu is a Gastroenterologist practicing medicine in Cincinnati, Ohio. Dr. Ofosu is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Jaundice, Choledocholithiasis, Gastrointestinal Bleeding, Endoscopy, and Stent Placement. Dr. Ofosu is currently accepting new patients.

Expertise in
51
conditions
Dr. Said I. Nabhan
Gastroenterology
Expertise in
51
conditions
Dr. Said I. Nabhan
Gastroenterology
Referral may be required
Before you request

Cincinnati GI

4805 Montgomery Road, Suite 160, 
Cincinnati, OH 
 (3.3 miles away)
513-721-5300
Languages Spoken:
English, Arabic, Arabic - Jordanian, French
See accepted insurances
Accepting New Patients

Said Nabhan is a Gastroenterologist practicing medicine in Cincinnati, Ohio. Dr. Nabhan is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Lower Esophageal Ring, Benign Esophageal Stricture, Colitis, Endoscopy, and Gastrectomy. Dr. Nabhan is board certified in American Board Of Internal Medicine, Gastroenterology - 1997, American Board Of Internal Medicine - 1994, and American Board Of Internal Medicine. Dr. Nabhan is currently accepting new patients.

Expertise in
51
conditions
Dr. Mark J. Lybik
Gastroenterology
Expertise in
51
conditions
Dr. Mark J. Lybik
Gastroenterology
Referral may be required
Before you request

Gastro Health

11333 Cornell Park Drive, Suite 200, 
Blue Ash, OH 
 (10.9 miles away)
513-751-6667
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Lybik is a Gastroenterologist practicing medicine in Blue Ash, Ohio. Dr. Lybik is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Childhood Pancreatitis, Bile Duct Obstruction, Acute Pancreatitis, Gastrectomy, and Endoscopy. Dr. Lybik is board certified in American Board Of Internal Medicine. Dr. Lybik is currently accepting new patients.

Frequently Asked Questions about Dr. Kenneth E. Sherman

How do I make an appointment with Dr. Kenneth E. Sherman?

You can book an appointment with Dr. Kenneth E. Sherman by calling their office at 513-475-7505. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kenneth E. Sherman a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kenneth E. Sherman is classified as an Elite expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kenneth E. Sherman specialize in?

While Dr. Kenneth E. Sherman is a Gastroenterology, they have specific expertise in Hepatitis, Cirrhosis, and Hepatitis C. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Kenneth E. Sherman participate in research or clinical trials?

Yes. Dr. Kenneth E. Sherman has published 168 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Kenneth E. Sherman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kenneth E. Sherman accept my insurance?

Dr. Kenneth E. Sherman accepts most major insurance plans, including Anthem BCBS and CareSource. We recommend calling the office directly at 513-475-7505 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sherman's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile